Richard Bartram - 12 Sep 2024 Form 4 Insider Report for MBX Biosciences, Inc. (MBX)

Role
Chief Financial Officer
Signature
/s/ Richard Bartram
Issuer symbol
MBX
Transactions as of
12 Sep 2024
Net transactions value
$0
Form type
4
Filing time
13 Sep 2024, 17:13:35 UTC
Previous filing
16 Mar 2022
Next filing
05 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBX Stock Option (Right to Buy) Award $0 +42,578 $0.000000 42,578 12 Sep 2024 Common Stock 42,578 $16.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.